Thalidomide in AIDS: one institution's response to the challenge of an experimental protocol.
Killip
T
T
Beth Israel Medical Center, New York City.
Harlow
N
N
D000014:Abnormalities, Drug-Induced / Q000209:etiology; D000163:Acquired Immunodeficiency Syndrome / Q000150:complications*; D004941:Esophagitis / Q000150:complications / Q000188:drug therapy; D004992:Ethics, Medical; D005260:Female; D006801:Humans; D011247:Pregnancy; D016032:Randomized Controlled Trials as Topic; D013281:Stomatitis, Aphthous / Q000150:complications / Q000188:drug therapy; D013792:Thalidomide / Q000009:adverse effects / Q000627:therapeutic use*; D014930:Women; D014933:Women's Rights
D013792:Thalidomide